Concepedia

Simon Whiteoak

SW

4

Publications

261

Citations

4

H-Index

2017

Active since

Affiliations

University of Southampton(Current)

University Hospital Southampton NHS Foundation Trust

Simon Whiteoak is an author at University of Southampton.

Publications per year

2017–2022

4

Publications

4

Biosimilar Infliximab in Inflammatory Bowel Disease: Outcomes of a Managed Switching Programme

Violeta Razanskaite, Marion Bettey, Louise Downey et al. · Journal of Crohn s and Colitis · 2017 · 155 citations · Full text

MicroRNA-31 and MicroRNA-155 Are Overexpressed in Ulcerative Colitis and Regulate IL-13 Signaling by Targeting Interleukin 13 Receptor α-1

Markus Gwiggner, Rocío T. Martínez-Núñez, Simon Whiteoak et al. · Genes · 2018 · 55 citations · Full text

Neutralising antibody potency against SARS-CoV-2 wild-type and omicron BA.1 and BA.4/5 variants in patients with inflammatory bowel disease treated with infliximab and vedolizumab after three doses of COVID-19 vaccine (CLARITY IBD): an analysis of a prospective multicentre cohort study

Zhigang Liu, Kaixing Le, Xin Zhou et al. · The Lancet. Gastroenterology & hepatology · 2022 · 35 citations · Full text

MicroRNA-31 Targets Thymic Stromal Lymphopoietin in Mucosal Infiltrated CD4+ T Cells: A Role in Achieving Mucosal Healing in Ulcerative Colitis?

Simon Whiteoak, Andrew Claridge, Clare A. Balendran et al. · Inflammatory Bowel Diseases · 2018 · 16 citations · Full text

Rows per page

1–4 of 4